Professor Vlado Perkovic, of The George Institute, discusses the results of the CREDENCE kidney disease trial (with subtitles)

Related Content

New research building a clearer picture of kidney disease in Asia

Date published: Node Type: News

Study finds drug class provides cardiovascular benefit for all patients with type 2 diabetes

Date published: Node Type: Media release